Can Targeted Peptide Therapies Mitigate Long-Term Endocrine Damage from Untreated Insulin Resistance?
Targeted peptide therapies can precisely recalibrate metabolic pathways and hormonal balance, mitigating long-term endocrine damage from untreated insulin resistance.
HRTioJuly 22, 2025